In this Interview, NewsMedical talks to Ben Krenke about the Spectrum CE system for Forensic laboratory workflow.
As cash runs tight, bluebird plunges after pricing sickle cell gene therapy well above competitor and failing to win review voucher
Investors reacted negatively to bluebird bio’s pricing plans for its new sickle cell therapy, as well as the lack of a valuable priority review voucher